tiprankstipranks
Advertisement
Advertisement

Acadia Healthcare Shareholders Back Directors and Governance Proposals

Story Highlights
  • On May 6, 2026, Acadia shareholders re-elected three Class III directors, reinforcing board continuity.
  • Investors approved incentive plan changes, endorsed executive pay, and ratified Ernst & Young as auditor for 2026.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Acadia Healthcare Shareholders Back Directors and Governance Proposals

Claim 55% Off TipRanks

Acadia Healthcare ( (ACHC) ) has issued an update.

At its annual meeting of stockholders on May 6, 2026, Acadia Healthcare shareholders elected Daniel J. Cancelmi, Michael J. Fucci and Patrice A. Harris as Class III directors to serve until the 2029 annual meeting or until their successors are in place. The meeting results reinforced the company’s existing board composition and governance structure, signaling continuity in oversight as Acadia continues to operate its network of behavioral health facilities.

Stockholders also approved a second amendment to the company’s Amended and Restated Incentive Compensation Plan and gave non-binding advisory approval to the compensation of its named executive officers. In addition, shareholders ratified Ernst & Young LLP as Acadia’s independent registered public accounting firm for the fiscal year ending December 31, 2026, affirming the company’s executive pay practices and auditor relationship for the coming year.

The most recent analyst rating on (ACHC) stock is a Buy with a $39.00 price target. To see the full list of analyst forecasts on Acadia Healthcare stock, see the ACHC Stock Forecast page.

Spark’s Take on ACHC Stock

According to Spark, TipRanks’ AI Analyst, ACHC is a Neutral.

The score is held back primarily by weakened financial performance (large recent losses, higher leverage, and negative free cash flow). Offsetting this, the latest earnings call was constructive with a Q1 beat and raised full-year profitability guidance, while technicals show an improving intermediate trend. Valuation remains constrained by unprofitability and the lack of a dividend yield.

To see Spark’s full report on ACHC stock, click here.

More about Acadia Healthcare

Acadia Healthcare Company, Inc. is a holding company whose direct and indirect subsidiaries own and operate acute inpatient psychiatric hospitals, specialty treatment facilities, comprehensive treatment centers, residential treatment centers and outpatient behavioral healthcare clinics. The company focuses on serving behavioral healthcare and recovery needs across communities in the U.S. and Puerto Rico, providing a broad continuum of mental health and addiction treatment services.

Average Trading Volume: 3,582,959

Technical Sentiment Signal: Sell

Current Market Cap: $2.55B

For a thorough assessment of ACHC stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1